RxDoctor Payments Data

Lindsey Ellerbrook, MD

Family Medicine · Evansville, INNPI 1710186879

Payments from drug & device makers

$295in general payments, 2019–2025

Across 20 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shire North American Group Inc$57
  • Takeda Pharmaceuticals U.S.A., Inc.$57
  • AstraZeneca$34
  • Neos Therapeutics, LP$21
  • Duchesnay USA Incorporated$19
  • Lilly USA, LLC$16
  • plus $91 from 7 others

What the payments were for

  • Food & beverage$295100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$295 in reported general payments places this provider in the 40th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$26,876
Medicare patients
88
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$54,445
JanuviaSitagliptin Phosphate38$46,441
Spiriva HandihalerTiotropium Bromide26$29,139
VraylarCariprazine Hcl16$26,543
TrintellixVortioxetine Hydrobromide31$17,754
FarxigaDapagliflozin Propanediol17$17,627
TrulicityDulaglutide16$15,247
Janumet XrSitagliptin Phos/Metformin Hcl11$11,883
Breo ElliptaFluticasone/Vilanterol13$9,035
Aimovig AutoinjectorErenumab-Aooe11$7,906
Emgality PenGalcanezumab-Gnlm11$7,644
Sumatriptan Succinate18$7,001
SavellaMilnacipran Hcl12$5,938
Naltrexone Hcl11$4,677
Desvenlafaxine Succinate ErDesvenlafaxine Succinate27$3,433

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$12$54,44540 claims
AbbVieVraylar, Savella$13$32,48128 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$57$17,75431 claims
AstraZenecaFarxiga$34$17,62717 claims
Lilly USA, LLCTrulicity$16$15,24716 claims
GSKBreo Ellipta$12$9,03513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →